Gero Kramer

机构：University of Vienna, Comprehensive Cancer Center Vienna, Christian Doppler Laboratory for Thermoelectricity, Medical University of Vienna · ORCID：0000-0003-1982-6817

发表论文 326 篇 · 总被引 8782 次 · h-index 45

代表论文

LBA6 Phase III trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer (PSMAddition) (2025 · Annals of Oncology · 被引 42)
Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysis (2025 · European Urology Focus · 被引 19)
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study (2025 · Annals of Oncology · 被引 18)
Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer (2025 · BMC Cancer · 被引 7)
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer (2025 · European Urology Oncology · 被引 3)
Use of 177Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer (2025 · Wiener klinische Wochenschrift · 被引 3)